// App-Quantinova.ai

e13562 : Expression of eIF4E relevant biomarkers detected in circulating tumor cells from metastatic NSCLC and prostate cancer patients using antibody-independent ApoStream technology.

Researchers

Presenter

  • Weiguo Wu

Principal Investigators

  • Jacky Woo

  • Vladislava O. Melnikova

  • Margaret Pace

  • Vishal Gupta

  • Elena Jouravleva

  • Kenna Lynn Anderes

  • Elizabeth J. Ackermann

  • T. Jesse Kwoh

  • Darren W. Davis

Medical Centers

  • ApoCell, Inc., Houston, TX

  • Ionis Pharmaceuticals, Carlsbad, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

  • Non Small Cell Lung cancer

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Epithelial Cell Adhesion Molecule

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A